FIELD: medicine.
SUBSTANCE: group of inventions relates to degarelix and methods for the manufacture of a medicinal product containing degarelix substance. Substance includes degarelix, acetic acid in an amount of 4.5 to 10.0% (w/w), water in an amount of 10% (w/w). After dissolution in water of 20 mg of degarelix as a free base and mannitol in an amount of 2.5 wt. %, the substance exhibits a viscosity of up to 3.2 mPa⋅C. Viscosity is measured with a viscometer with a cone-plane measuring system with D=60 mm and 1°. Shear rate is increased from 0 to 500 s-1 for 20 steps at a constant temperature of 20±0.2°C. Methods for the preparation of a medicament substance of degarelix and the manufacture of a lyophilized drug product of degarelix are also provided.
EFFECT: inventions make it possible to manufacture medical products with a viscosity and bioavailability that provides a sustained release of the active substance for several months depending on the dosage.
12 cl, 3 dwg, 2 tbl, 8 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PRODUCING BORTEZOMIB LYOPHILIZATE AND A PHARMACEUTICAL COMPOSITION CONTAINING BORTEZOMIB IN FORM OF A STABLE LYOPHILIZED PRODUCT OBTAINED BY SAID METHOD | 2018 |
|
RU2696854C1 |
PHARMACEUTICAL COMPOSITION OF NEUROPROTECTIVE ACTION FOR PARENTERAL APPLICATION ON BASIS OF HEXAMETHYLENEDIAMINE BIS-(N-MONOSUCCINYL-L-GLUTAMIL-L-LYSINE) IN LYOPHILIZED DOSAGE FORM | 2017 |
|
RU2678203C2 |
BORTEZOMIB LYOPHILIZATE PRODUCTION METHOD AND THE BORTEZOMIB CONTAINING PHARMACEUTICAL COMPOSITION IN THE FORM OF STABLE LYOPHILIZATED PRODUCT PRODUCED BY SAID METHOD | 2017 |
|
RU2659160C1 |
NEW METHOD FOR STABILIZATION OF A BIOPHARMACEUTICAL MEDICINAL PRODUCT IN MANUFACTURE THEREOF | 2017 |
|
RU2744630C2 |
LYOPHILISED FORMULATIONS OF BENDAMUSTINE HYDROCHLORIDE | 2014 |
|
RU2679614C2 |
SUSTAINED TYPE HUMAN GROWTH HORMONE PREPARATION | 2014 |
|
RU2683823C2 |
PHARMACEUTICAL COMPOSITION OF FUSION PROTEIN TACI-FC | 2020 |
|
RU2779387C1 |
LYOPHILISED COMPOSITIONS CCI-779 | 2004 |
|
RU2345772C2 |
ECTEINASCIDIN AND DISACCHARIDE-CONTAINING COMPOSITIONS | 2005 |
|
RU2382647C2 |
METHOD FOR OBTAINING GLATIRAMER ACETATE PRODUCT | 2015 |
|
RU2669769C2 |
Authors
Dates
2018-06-13—Published
2013-05-31—Filed